Cargando…
FCGR2A as one novel potential target for poor survival prognosis of clear cell renal cell carcinoma
Clear cell renal cell carcinoma (ccRCC) is the most common type of renal cell carcinoma. Immunoglobulin FcγRIIa receptor (FCGR2A) has been implicated in various cancers, however, its role on ccRCC is not well studied. A total of 151 patients with ccRCC were recruited for the study. Cox proportional...
Autores principales: | Fu, Taozhu, Zhang, Lianfeng, Zuo, Meini, Li, Feng, Shi, Changjin, Chen, Hongrun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019103/ https://www.ncbi.nlm.nih.gov/pubmed/36930102 http://dx.doi.org/10.1097/MD.0000000000033324 |
Ejemplares similares
-
Inhibition of apoptosis through AKT-mTOR pathway in ovarian cancer and renal cancer
por: Chen, Hongrun, et al.
Publicado: (2023) -
A-kinase interacting protein 1 high expression correlates with advanced tumor stage and poor overall survival in surgical patients with clear cell renal cell carcinoma
por: Peng, Huimin, et al.
Publicado: (2020) -
An immune scores-based nomogram for predicting overall survival in patients with clear cell renal cell carcinoma
por: Wu, Zhulin, et al.
Publicado: (2020) -
FCGR2B as a prognostic and immune microenvironmental marker for gliomas based on transcriptomic analysis
por: Sun, Zhimin, et al.
Publicado: (2023) -
miR‐21 modification enhances the performance of adipose tissue‐derived mesenchymal stem cells for counteracting urethral stricture formation
por: Feng, Zongcheng, et al.
Publicado: (2018)